Skip to content

Clinical trials

Tachycardia, Ventricular trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tachycardia, Ventricular Phase: Not applicable Country / region: United States Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20064
20071
20081
20104
20111
20123
20131
20143
20156
20163
20171
20185
20192
20202
20213
20224
20234
20245
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting14
Terminated9
Withdrawn7
Enrolling by invitation3
Not yet recruiting2
Unknown status2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vivek Reddy5
Boston Scientific Corporation3
University of Pennsylvania3
Duke University2
Johns Hopkins University2
Medtronic Cardiac Ablation Solutions2
Thermedical, Inc.2
University of Arizona2
University of California, Los Angeles2
Varian, a Siemens Healthineers Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tachycardia, Ventricular66
Ventricular Fibrillation11
Arrhythmias, Cardiac10
Death, Sudden, Cardiac10
Heart Diseases4
Myocardial Ischemia4
Ventricular Premature Complexes4
Cardiovascular Diseases3
Myocardial Infarction3
Pathologic Processes3

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.